SCHEMBL29355012

SCHEMBL29355012

O=C1C=C(S(=O)(=O)[O-])c2ccccc2C1=O.[Na+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 9/20 1.00
PTPRC P08575 4/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.48
PTPN22 Q9Y2R2 1/20 0.48
NSD2 O96028 1/20 0.48
HKDC1 Q2TB90 1/20 0.48
CDC25B P30305 2/20 0.46
PTPRF P10586 1/20 0.46
MALT1 Q9UDY8 2/20 0.44
PKLR P30613 1/20 0.43
DNMT1 P26358 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL423603 1.00 PTPN1 (1.00) PTPN1PTPRCKDM4EALDH1A1CYP3A4
Potassium Ion SCHEMBL379119 0.96 PTPN1 (0.92) PTPN1PTPRCKDM4EALDH1A1CYP3A4
Potassium Ion SCHEMBL30585392 0.96 PTPN1 (0.92) PTPN1PTPRCKDM4EALDH1A1CYP3A4
SCHEMBL9233999 0.96 PTPN1 (0.92) PTPN1PTPRCKDM4EALDH1A1CYP3A4
SCHEMBL465089 0.84 PTPN1 (0.72) PTPN1PTPRCKDM4EALDH1A1CYP3A4
SCHEMBL30708248 0.84 PTPN1 (0.72) PTPN1PTPRCKDM4EALDH1A1CYP3A4
SCHEMBL9237165 0.80 PTPN1 (0.67) PTPN1PTPRCKDM4EALDH1A1CYP3A4
SCHEMBL31401925 0.80 PTPN1 (0.67) PTPN1PTPRCKDM4EALDH1A1CYP3A4
Potassium Ion SCHEMBL29359597 0.80 PTPN1 (0.67) PTPN1PTPRCKDM4EALDH1A1CYP3A4
Lithium Ion SCHEMBL7788948 0.80 PTPN1 (0.67) PTPN1PTPRCKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024249876-A2 BIOSENSOR BASED ON A NEAR FIELD COMMUNICATION USING DIRECT ELECTRON TRANSFER THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2024-12-05 WO claimed
WO-2024205656-A1 FIELD TEST FOR DETERMINING CONCENTRATION OF EMULSIFIERS IN DRILLING FLUIDS USING DYES HALLIBURTON ENERGY SERVICE, INC. (US) 2024-10-03 WO claimed
CN-115504866-B Preparation method and application of 4-methoxy-2-naphthol 阜阳欣奕华制药科技有限公司 2023-09-26 CN claimed
CN-116454419-A Self-deoxidizing electrolyte additive for zinc metal battery, electrolyte and zinc metal battery 天津大学 2023-07-18 CN claimed
CN-113504212-B Method and device for detecting organic amine in liquid phase, readable storage medium and equipment 中国科学院上海微系统与信息技术研究所 2022-11-08 CN claimed
WO-2026102306-A1 COMPOSITIONS FOR PROTEIN STABILIZATION AND RELATED METHODS VITACYTE, LLC (US) 2026-05-15 WO disclosed
EP-4729622-A1 MODIFIER FOR PROTEIN-CONTAINING COMPOSITION Amano Enzyme Inc. (JP) 2026-04-22 EP disclosed
EP-4729611-A1 LIQUID ENZYME PREPARATION Amano Enzyme Inc. (JP) 2026-04-22 EP disclosed
EP-4702845-A1 METHOD FOR PRODUCING PLANT-BASED CHEESE Amano Enzyme Inc. (JP) 2026-03-04 EP disclosed
EP-4691259-A1 METHOD FOR PRODUCING PROCESSED PROTEIN-CONTAINING COMPOSITION Amano Enzyme Inc. (JP) 2026-02-11 EP disclosed
WO-2025262138-A2 THERMOPHILIC BACTERIUM COMPRISING A SURFACE-DISPLAYED CARBONIC ANHYDRASE DANMARKS TEKNISKE UNIVERSITET (DK) 2025-12-26 WO disclosed
US-20250387469-A1 Use of the ultrafiltration for producing purified allergenic extracts ANALLERGO S P A (IT) 2025-12-25 US disclosed
US-11499145-B2 Truncated and modified serratiopeptidase and polynucleotides encoding the same HELIX INSTITUTE FOR MEDICAL & BIOLOGICAL SCIENCES LLC 2022-11-15 US disclosed
CN-113504212-B Method and device for detecting organic amine in liquid phase, readable storage medium and equipment 中国科学院上海微系统与信息技术研究所 2022-11-08 CN disclosed
US-11489184-B2 Electrolyte including mixture of active material and precursor thereof FOUNDATION FOR RESEARCH AND BUSINESS, SEOUL NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY (KR) 2022-11-01 US disclosed
US-20220326172-A1 ELECTROCHEMICAL MEASUREMENT OF PRIMARY OR SECONDARY AMINES UNIVERSITEIT ANTWERPEN (BE) 2022-10-13 US disclosed
WO-2022181810-A1 METHOD FOR PRODUCING STRETCHING CHEESE SUBSTITUTE アマノ エンザイム ユーエスエー カンパニー,リミテッド 2022-09-01 WO disclosed
US-20220022820-A1 SYSTEMS AND METHODS FOR HOME TRANSDERMAL ASSESSMENT OF GASTROINTESTINAL FUNCTION MEDIBEACON INC. 2022-01-27 US disclosed
US-20220023396-A1 METHOD FOR IMPROVING INTESTINAL FLORA HIROSHIMA UNIVERSITY (JP) 2022-01-27 US disclosed
WO-2022020174-A1 SYSTEMS AND METHODS FOR HOME TRANSDERMAL ASSESSMENT OF GASTROINTESTINAL FUNCTION MEDIBEACON INC. (US) 2022-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387469-A1 Use of the ultrafiltration for producing purified allergenic extracts CMA1, PSMB1, EXOSC4 PTPN1 2187/4885PTPRC 1586/4885KDM4E 1755/4885
US-11489184-B2 Electrolyte including mixture of active material and precursor thereof NQO1, HCN2, HPGD PTPN1 3574/4885PTPRC 4163/4885KDM4E 4051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.